Fraternal Order of Eagles Diabetes Research Center and Division of Endocrinology and Metabolism, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Antioxid Redox Signal. 2021 Aug 1;35(4):252-269. doi: 10.1089/ars.2020.8220. Epub 2021 Feb 16.
Mitochondria-derived reactive oxygen species (mtROS) are by-products of normal physiology that may disrupt cellular redox homeostasis on a regular basis. Nonetheless, failure to resolve sustained mitochondrial stress to mitigate high levels of mtROS might contribute to the etiology of numerous pathological conditions, such as obesity, insulin resistance, and cardiovascular disease (CVD). Notably, recent studies have demonstrated that moderate mitochondrial stress might result in the induction of different stress response pathways that ultimately improve the organism's ability to deal with subsequent stress, a process termed mitohormesis. mtROS have been shown to play a key role in regulating this adaptation. mtROS regulate the convergence of different signaling pathways that, when disturbed, might impair cardiometabolic health. Conversely, mtROS seem to be required to mediate activation of prosurvival pathways, contributing to improved cardiometabolic fitness. In the present review, we will primarily focus on the role of mtROS in the activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant pathway and examine the role of endoplasmic reticulum (ER) stress in coordinating the convergence of ER stress and oxidative stress signaling through activation of Nrf2 and activating transcription factor 4 (ATF4). The mechanisms underlying cardiometabolic protection in response to mitochondrial stress have only started to be investigated. Integrated understanding of how mtROS and ER stress cooperatively promote activation of prosurvival pathways might shed mechanistic insight into the role of mitohormesis in mediating cardiometabolic protection and might inform future therapeutic avenues for the treatment of metabolic diseases contributing to CVD. 35, 252-269.
线粒体来源的活性氧 (mtROS) 是正常生理的副产物,它可能会定期破坏细胞的氧化还原稳态。然而,如果不能解决持续的线粒体应激,以减轻高水平的 mtROS,可能会导致许多病理状况的发生,如肥胖、胰岛素抵抗和心血管疾病 (CVD)。值得注意的是,最近的研究表明,适度的线粒体应激可能会导致不同应激反应途径的诱导,最终提高机体应对后续应激的能力,这一过程被称为线粒体适应。mtROS 被证明在调节这种适应中起着关键作用。mtROS 调节不同信号通路的汇聚,当这些信号通路受到干扰时,可能会损害心脏代谢健康。相反,mtROS 似乎需要介导存活相关途径的激活,从而有助于改善心脏代谢适应性。在本综述中,我们将主要关注 mtROS 在核因子红细胞 2 相关因子 2 (Nrf2) 抗氧化途径激活中的作用,并研究内质网 (ER) 应激在通过激活 Nrf2 和激活转录因子 4 (ATF4) 协调 ER 应激和氧化应激信号汇聚中的作用。线粒体应激引起的心脏代谢保护的机制才刚刚开始被研究。综合理解 mtROS 和 ER 应激如何协同促进存活相关途径的激活,可能为线粒体适应介导心脏代谢保护的作用提供机制上的深入了解,并为治疗导致 CVD 的代谢疾病的未来治疗途径提供信息。 35, 252-269.